Radial acquires MSO behind Mindful Health Solutions to build largest US brain medicine network
What's the deal? Radial has acquired the management services organisation (MSO) supporting Mindful Health SolutionsDealroom has a profile for this one. Try Dealroom →, one of the top interventional psychiatry groups in the US. The combined management company will support what Radial says is the country's largest network of brain medicine clinics. Terms were not disclosed.
What does each side do? Mindful Health Solutions is an interventional psychiatry group; Radial runs RadialOS, an AI-enabled operating system that matches patients to treatments, coordinates care, and measures outcomes over time. The expanded network spans more than 100 clinicians nationwide.
What's the endgame? The network treats major depressive disorder, PTSD, obsessive compulsive disorder, suicidality, and tardive dyskinesia using neuromodulation and rapid-acting medications such as Spravato. Radial plans to add psychedelic medicines and, over time, study how these treatments affect neurological conditions including Parkinson's disease.
Why now? Since the 1980s, psychiatry has leaned on SSRIs and talk therapy, which often fall short for high-acuity conditions. Newer brain medicine treatments show remission rates as high as 79%, versus 5-30% for traditional approaches, according to Radial.
What it means for patients: Fergal Foley, a retired US Army officer who developed PTSD symptoms in the 1970s, reached remission through transcranial magnetic stimulation after decades of medications and talk therapy failed.
"We shouldn't rely on just 'pill-based psychiatry' anymore," said Owen Muir, co-founder and chief scientific officer of Radial. "Treating the whole patient has a life-changing impact."
The signal: The deal reflects consolidation around evidence-backed brain medicine, as clinics race to scale neuromodulation and next-generation therapies before psychedelics reach the mainstream. Radial's bet is that an AI operating system, not just new drugs, will close the gap between clinical research and everyday care.
Image credit: jurvetson
Read more: PR Newswire
